APGE
NASDAQ
$134.15
Apogee Therapeutics Inc (APGE)
Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $130.53 (-2.70%)
Market Cap
$10B
Free Cash Flow Yield
-2.34%
Beta (5Y)
1.25
Price Chart
Valuation
Market Cap$10B
P/B8.07
Profitability
EBITDA-$304M
EPS-$4.23
Financial Health
Free Cash Flow Yield-2.34%
Growth & Risk
Beta (5Y)1.25
Sharpe Ratio2.01